Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775309
                    [Title] => Efforts on to finally eliminate leprosy
                    [Summary] => 
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

LEPROSY STAKEHOLDERS SYMPOSIUM

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775309
                    [Title] => Efforts on to finally eliminate leprosy
                    [Summary] => 
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Efforts on to finally eliminate leprosy

February 9, 2012 - 12:00am

Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.

Science and Environment